Fighting cancer: Rocky path for immunotherapy – Financial Times
Financial Times |
Fighting cancer: Rocky path for immunotherapy
Financial Times High hopes that new immunotherapy drugs would prove to have benefits over toxic chemotherapy were dashed by large-scale trials, says David Crow. Pharmaceutical groups are now working on combinations of the immunotherapies and using them with … |
